Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: against (297), hostile (2), resistant (74)

Anti-CGRP monoclonal antibodies (mAbs) for the prevention of episodic and chronic migraine - patient information

Description: This factsheet contains information about a preventative treatment for episodic and chronic migraine called anti-CGRP monoclonal antibodies (mAbs).
Url: /Media/UHS-website-2019/Patientinformation/Brain-and-spine/Anti-CGRP-monoclonal-antibodies-mAbs-for-the-prevention-of-episodic-and-chronic-migraine-3075-PIL.pdf

Enhanced recovery after anti-reflux surgery - patient information

Description: This factsheet is designed to help increase your understanding of the enhanced recovery programme, and to enable you an
Url: /Media/UHS-website-2019/Patientinformation/Surgery/Enhanced-recovery-after-anti-reflux-surgery-3319-PIL.pdf

Taking oral systemic anti-cancer therapy (SACT) - patient information

Description: This factsheet gives information about taking oral systemic anti-cancer therapy (SACT).
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Taking-oral-systemic-anti-cancer-therapy-SACT-3103-PIL.pdf

Routine pregnancy testing information for young people receiving systemic anti-cancer treatment (SACT) - patient information

Description: This factsheet contains information about routine pregnancy testing for young people receiving systemic anti-cancer treatment (SACT).
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Routine-pregnancy-testing-information-for-young-people-receiving-systemic-anti-cancer-treatment-SACT-3214-PIL.pdf

Systemic anti-cancer therapy (SACT) extravasation - patient information

Description: This factsheet explains what systemic anti-cancer therapy (SACT) extravasation is, what causes it and the signs you need to be
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Systemic-anti-cancer-therapy-SACT-extravasation-3918-PIL.pdf

Nintedanib - patient information

Description: This factsheet explains what Nintedanib is, why you have been prescribed it, how to take it and the potential side effects
Url: /Media/UHS-website-2019/Patientinformation/Respiratory/Nintedanib-3212-PIL.pdf

Pirfenidone - patient information

Description: This factsheet explains what Pirfenidone is, why you have been prescribed it, how to take it and the potential side effects
Url: /Media/UHS-website-2019/Patientinformation/Respiratory/Pirfenidone-3211-PIL.pdf

Anti-VEGF injection treatment - patient information

Description: You have been given this factsheet because your doctor has recommended anti-VEGF injection treatment for your eye condition.
Url: /Media/UHS-website-2019/Patientinformation/Eyes/Anti-VEGF-injection-treatment-1331-PIL.pdf

Anti-VEGF injection treatment aftercare - patient information

Description: Anti-VEGF injections are used to treat conditions that can cause abnormal blood vessels to leak under the retina (the layer
Url: /Media/UHS-website-2019/Patientinformation/Eyes/Anti-VEGF-injection-treatment-aftercare-1365-PIL.pdf

BEACON protocol v8.0 07Mar2023 signed

Description: A randomised phase IIb trial of BE AC v izumab added to Temozolomide O ± Irin tecan for children with N refractory/relapsed euroblastoma Version 8
Url: /Media/UHS-website-2019/Docs/PaediatricOncology/beacon-protocol-v8.0-07mar2023-signed.pdf

1 to 10 of 417

Previous 1 2 3 4 5 … Next